1. HR+HER2− breast cancers with growth factor receptor–mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells. Issue 3 (March 2017) Authors: Desai, Krisha; Aiyappa, Radhika; Prabhu, Jyothi S; Nair, Madhumathy G; Lawrence, Patrick Varun; Korlimarla, Aruna; CE, Anupama; Alexander, Annie; Kaluve, Rohini S; Manjunath, Suraj; Correa, Marjorrie; Srinath, BS; Patil, Shekhar; Kalamdani, Anjali; Prasad, MSN; Sridhar, TS Journal: Tumor biology Issue: Volume 39:Issue 3(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗